Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Turkey Pursues Local Manufacture Of Hepatitis A Vaccine

This article was originally published in PharmAsia News

Executive Summary

While preparing Turkey's legal and business infrastructure for the local production of critical drugs and vaccines, the Ministry of Health has announced that first project will be a hepatitis A vaccine. The work on a related incentives package for possible foreign partners is almost complete and the project will be launched this year.



Related Companies